CTLT Catalent Inc

Price (delayed)

$104.00

Market cap

$17.72B

P/E Ratio

34.1

Dividend/share

N/A

EPS

$3.05

Enterprise value

$19.95B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Catalent, Inc. is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It ...

Highlights

CTLT's equity has soared by 70% year-on-year and by 7% since the previous quarter
The company's EPS has surged by 64% QoQ
The debt has grown by 5% from the previous quarter

Key stats

What are the main financial stats of CTLT
Market
Shares outstanding
170.34M
Market cap
$17.72B
Enterprise value
$19.95B
Valuations
Price to earnings (P/E)
34.1
Price to book (P/B)
4.77
Price to sales (P/S)
4.71
EV/EBIT
25.87
EV/EBITDA
18.94
EV/Sales
5.31
Earnings
Revenue
$3.76B
EBIT
$771.1M
EBITDA
$1.05B
Free cash flow
-$187.5M
Per share
EPS
$3.05
Free cash flow per share
-$1.1
Book value per share
$21.81
Revenue per share
$22.07
TBVPS
$31.84
Balance sheet
Total assets
$8.77B
Total liabilities
$4.7B
Debt
$3.22B
Equity
$3.71B
Working capital
$1.64B
Liquidity
Debt to equity
0.87
Current ratio
2.44
Quick ratio
1.67
Net debt/EBITDA
2.12
Margins
EBITDA margin
28%
Gross margin
33.2%
Net margin
14.8%
Operating margin
15%
Efficiency
Return on assets
6.1%
Return on equity
15.1%
Return on invested capital
12.9%
Return on capital employed
10.1%
Return on sales
20.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CTLT stock price

How has the Catalent stock price performed over time
Intraday
-0.76%
1 week
0.48%
1 month
-4.81%
1 year
42.06%
YTD
-0.07%
QTD
-1.24%

Financial performance

How have Catalent's revenue and profit performed over time
Revenue
$3.76B
Gross profit
$1.25B
Operating income
$562.9M
Net income
$556.8M
Gross margin
33.2%
Net margin
14.8%
Catalent's operating income has surged by 69% YoY and by 17% QoQ
The net income has soared by 61% from the previous quarter
The net margin has grown by 48% from the previous quarter
Catalent's gross profit has increased by 38% YoY and by 11% from the previous quarter

Growth

What is Catalent's growth rate over time

Valuation

What is Catalent stock price valuation
P/E
34.1
P/B
4.77
P/S
4.71
EV/EBIT
25.87
EV/EBITDA
18.94
EV/Sales
5.31
The company's EPS has surged by 64% QoQ
The stock's price to earnings (P/E) is 34% less than its 5-year quarterly average of 51.9 and 34% less than its last 4 quarters average of 51.6
CTLT's equity has soared by 70% year-on-year and by 7% since the previous quarter
The price to book (P/B) is 3.7% higher than the last 4 quarters average of 4.6
CTLT's price to sales (P/S) is 74% higher than its 5-year quarterly average of 2.7 and 7% higher than its last 4 quarters average of 4.4
The revenue has increased by 31% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Catalent business performance
Catalent's return on equity has surged by 165% YoY and by 51% QoQ
CTLT's return on invested capital has surged by 122% year-on-year and by 50% since the previous quarter
The company's return on sales has surged by 97% YoY and by 44% QoQ
The company's return on assets has surged by 61% QoQ

Dividends

What is CTLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CTLT.

Financial health

How did Catalent financials performed over time
Catalent's total assets is 87% more than its total liabilities
The current ratio is up by 28% year-on-year
Catalent's total assets has increased by 24% YoY and by 7% from the previous quarter
The debt is 13% less than the equity
CTLT's equity has soared by 70% year-on-year and by 7% since the previous quarter
The company's debt to equity fell by 40% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.